Skip to main content

Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish

2023 can be the year of biotechs after two consecutive years of negative or barely positive returns.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.